Clinical Interests: Global newborn health and improving healthcare delivery through evidence‐based medicine

Scholarly Focus: I have two main scholarly areas of focus. (1)Low‐cost interventions for resource‐limited settings targeting early neonatal nutrition, and (2) studying the impact of maternal inflammation/infection (namely maternal periodontitis) and its effects on neonatal outcomes.

Research Funding:

2020‐2022 H2neO: Creating an Affordable and Accessible Means to Provide Intravenous Fluids to Neonates in Low‐Resourced Settings Globally. CoMotion Innovation Gap Fund. Role: PI, Total Award: $50,000

2021                       ProtectIV: Affordable and Accessible Neonatal Intravenous Infiltration Detection in Low‐ Resourced Settings. M.J. Murdock Diagnostics Foundry for Translational Research Pilot Grant. Role: PI, Total Award: $9,000

2021                       pHast Cam: Development of a low‐cost, rapid blood pH detector for assessment of neonatal hypoxic ischemic encephalopathy after birth in low‐resourced settings. M.J. Murdock Diagnostics Foundry for Translational Research Pilot Grant. Role: Co‐I, Total Award: $9,000

Administration/Education Roles: Locally, Dr. Valentine serves on the Advisory Board for the Engineering Innovation in Health (EIH) Program at the University of Washington. Through EIH, he has helped oversee the development of three innovations all focused on providing affordable ways to provide intravenous fluids or point‐of‐care diagnostics to neonates in low‐resourced settings globally. Additionally, he serves on the Perinatal Prematurity Collaborative Alliance Team for St. Joseph’s Hospital/CHI Franciscan Health System, in Tacoma, Washington, where he works on consistently improving practices aimed at optimizing care to premature neonates. He also serves as Co‐lead of ALIGN (Advancing Learning and Innovation in Global Neonatology) within the division of Neonatology. Internationally, Dr. Valentine servies on several working groups within the World Health Organization related to antenatal corticosteroid utilization, every newborn action plan, and core indicators for quality improvement for small and sick newborns.